The miss and our expectations that Q4 will face some of the same issues, EBIT for ’21 is likely down +40%. However, we do expect to do materially less revisions for ’22, i.e. 5-10%, as we expect a more normalized market and improved component availability.
Aktuellt
SENASTE
